Mutation patterns of resistance genes for macrolides, aminoglycosides, and rifampicin in non-tuberculous mycobacteria isolates from Kenya [version 5; peer review: 2 approved, 1 not approved]

Background: Non-tuberculous mycobacteria (NTM) treatment constitutes a macrolide-based antibiotic regimen in combination with aminoglycosides for Rapid-Growing Mycobacteria (RGM), and rifampicin for Slow-Growing Mycobacteria (SGM). Mutations in the anti-NTM drug target regions promote NTM evolution...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Wallace Bulimo, Marianne Mureithi, Frank Onyambu, Zakayo Mwangi, Grace Naeku
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	F1000 Research Ltd 2023-04-01
Rangatū:	F1000Research
Ngā marau:	Nontuberculous mycobacteria slow-growing mycobacteria rapid-growing mycobacteria macrolides aminoglycosides rifampicin eng
Urunga tuihono:	https://f1000research.com/articles/11-962/v5
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!